Academy Learn to Trade for FREE Copy Trading Webinars
Get it on Google Play
Download on the App Store
⚡ Trade +10,000 CFDs with Tight Raw Spreads. – Trade Now!
Top XM LEaderboard
Dis-Chem Pharmacies Ltd. JSE: DCP
R22.94 ▼ -0.95 (-3.98%) Prices delayed 15 min · Last updated: 2026-11-17 17:05:00
Open
23.84
Prev close
22.94
Day range
22.94 - 24.17
Volume
989 943
52-wk range
22.94 – 25.24
Market cap
19.73bn
P/E Ratio
22.02
EPS (ZARc)
104.20
Dividend Yield
1.81%
DPS (ZARc)
42 (cps)
Price performance
Intraday — 7D — 1M — 3M — 6M — 1Y — 3Y — 5Y — YTD —
Loading chart…
Analyst consensus
Consensus Chart
Key statistics
Market cap19.73bn
EPS104.20
P/E ratio22.02
Div. yield1.81%
DPS 42 (cps)
Issued shares860.08m
52-week range
R 22.94 R 25.24
R22.94
Price overview
Open23.84
Previous close22.94
Day range22.94 - 24.17
Volume989 943
52-week range22.94 – 25.24
Change▼ -0.95 (-3.98%)
P/E ratio22.02
EPS104.20
Dividend 42 (cps)
Dividend yield1.81%
Important dates
  • Feb 2026
    Prev Year End
  • Feb 2026 Final
    Released 29 May 2026
  • Final Div 0.1591872 ZAR
    Decl 29 May 2026, LDT 15 Jun 2026
  • Final Div 0.1591872 ZAR
    Decl 29 May 2026, Pay 22 Jun 2026
  • Aug 2026
    Half Year
  • Aug 2026 Interim
    Released 29 Oct 2026
  • Interim Div 0.2562181 ZAR
    Decl 29 Oct 2026, LDT 17 Nov 2026
  • 18 Nov 2026
    Today
  • Interim Div 0.2562181 ZAR
    Decl 29 Oct 2026, Pay 23 Nov 2026
  • Feb 2027
    Next Year End
  • Feb 2027 Final
    Unconfirmed for 28 May
  • Next Expected Final Div 0.1591872 ZAR
    Decl 29 May 2027, LDT 15 Jun 2027
  • Next Expected Final Div 0.1591872 ZAR
    Decl 29 May 2027, Pay 22 Jun 2027
  • 30 Jul 2027
    AGM Unconfirmed
  • Aug 2027
    Half Year
  • Aug 2027 Interim
    Unconfirmed for 29 Oct
  • Next Expected Interim Div 0.2562181 ZAR
    Decl 29 Oct 2027, LDT 17 Nov 2027
Financial results
ZAR million Aug 26 Aug 25
Turnover 22 974 21 274.30
Attributable Income 548.80 633.10
Market Cap (ZARm) 24 486.60 29 285.90
EPS (ZARc) 64.10 73.90
HEPS (Cont Ops)(ZARc) 64.30 73.80
DPS (ZARc) 25.62 29.42
Latest SENS announcements
  • Dis-Chem - directorate change
    2026-11-16 08:34:50
    Katlego Kobue has resigned from his position as Non-Executive Director (NED) with effect from the 12th of November 2026.
  • Dis-Chem interim results August 2026
    2026-10-29 17:19:33
    Revenue from contracts with customers went up by 8% to R23.0 billion (R21.3 billion) whilst gross profit firmed up by 8.6% to R5.1 billion (R4.7 billion). Operating profit before interest and equity accounted earnings went down by 10.5% to R1.0 billion (R1.1 billion). Profit attributable to equity holders decreased to R548.8 million (R633.1 million). Furthermore, headline earnings per share lowered to 64.3 cents per share (73.8 cents per share). Dividend A gross interim cash dividend of 25.62181 cents per share, in respect of the interim period ended 31 August 2026 has been declared based on 40% of headline earnings. This is a decrease of 12.9% from the prior comparable period. Group outlook For the seven-week period 1 September to 19 October 2026, Group revenue grew by 7.9% over the prior comparable period. • Retail revenue grew by 7.2%, supported by the opening of five retail pharmacy stores and the continued market share growth driven by Better Rewards. As per Nielsen IQ, September showed the strongest market share gains across the prevailing seven months with Dis-Chem front shop volume growth of 4.9% against total market (excluding Dis-Chem) volume growth of negative 2.6%. • Wholesale revenue to external customers grew by 12.4%. The revenue growth, market share gains and improved retail total income margin, highlights the sustainability of the Better Rewards programme. The Better Rewards programme serves the dual purpose of supporting business growth while offering customers value at the till as they remain constrained due to the current economic climate. Serving as a health funding mechanism that attracts and retains customers and drives frequency and supports basket size, the Better Rewards programme is now well established with brand and partner participation secured and sustainable funding agreements in place. Following the anniversary of Better Rewards, there will be an unwinding of the deflationary base effects created by the programme, with natural inflation returning to retail revenue. With the stabilisation of Better Rewards, further investment in promotional activity will be driven by predictive and adaptive offers executed through X, bigly labs. Including the 19 stores already trading in FY2027, 30 retail pharmacy stores are planned for the year. Five stores are trading with the SoTF format. All new stores will receive the SoTF format. Using X, bigly labs data-led commercial decisioning capability, retail stores are being prioritised for full SoTF revamp based on revenue and earnings uplift opportunity, with many revamps pulled forward ahead of a traditional revamp cycle. Since the launch of X, bigly labs, which houses the responsibility for the Group’s digital ambitions, R240 million has been deployed to re- platform Dis-Chem’s digital estate and the consequential transformation of the operational business beneath it. This capital investment in e-commerce has resulted in the re–engineering of the core commerce platform and the supporting retail capabilities, ensuring best-in- class cataloguing, pricing, fulfilment and order management. The business now runs on a modern, scalable foundation. The same approach is being followed for health digitization in the pharmacy and clinic. The Group has launched the first release of its new app to 22 000 customers, with the upcoming second release in the last quarter of FY2027 to a broader customer audience. Relative to the corresponding prior year period, the Group anticipates a more even distribution of earnings across 1H2027 and 2H2027 due to the higher invested cost base for X, bigly labs in 2H2026, contributing to an stronger full year earnings performance.
  • Dis-Chem Pharmacies Ltd. - Notification of Change
    2026-09-18 11:02:00
    The company has issued a statement regarding an interest in shares.
  • Dis-Chem - directorate change
    2026-09-15 17:03:44
    Dis-Chem has appointed Clifford Raphiri as an independent non-executive director, effective 21 September 2026. He will also serve on the Social and Ethics, and Remuneration and Nomination sub-committees. The Board confirms a fit and proper assessment has been completed, with no integrity concerns aside from his previous directorship at Murray and Roberts Holdings, which entered business rescue in November 2024; he resigned in January 2025.
  • Dis-Chem - results of annual general meeting
    2026-07-31 17:43:22
    Dis-Chem shareholders approved all resolutions at the AGM held on 31 July 2026. The meeting was attended by 93% of voteable shares, representing 92% of issued shares. Key approvals included all ordinary resolutions, with most receiving over 99% support, and two special resolutions, with approval rates of 87.82% and 98.98%. Notably, Resolution 8 received only 39.57% support. The results reflect strong shareholder backing for the company's governance and strategic proposals.
Peer comparison
Company Price (ZAR) Change Market cap
CLICKS (CLS) R 210.08 -1.13% —
DIS-CHEM (DCP) R 22.94 -3.98% —

People Also Watch

182.00
93.06
294.71
92.35

Today's Verdict

Today's verdict: Dis-Chem Pharmacies Ltd. price today in rands is R23.69, and the latest data points from charts and the live graph suggest a cautious stance rather than an aggressive chase. The share code DCP continues to show growth at a measured pace, so the current price forecast leans to consolidation as traders weigh how to buy, whether to buy or sell, and what the cost of entry looks like online. Dividend investors will note the payout profile alongside the dividend, while preference shares are best treated as a separate instrument from ordinary shares. With the stock for sale on the JSE, investors using a trading account can compare trading signals and the broader prediction before deciding on a purchase.

Live Share Data

LabelValue
Share Name & TickerDis-Chem Pharmacies Ltd. (DCP)
ExchangeJSE (Johannesburg Stock Exchange)
Sector & IndustryConsumer Staples / Pharmaceuticals & Drug Retail
Current Price23.69
Market Capitalization20.55bn
P/E Ratio22.93
Dividend Yield1.74
Trading Volume (Live Data)26 752
Recent Price Change-0.84
Data as of2026-11-17 10:03:05

Dis-Chem Pharmacies Ltd. Key Highlights

LabelValue
Current PriceR23.69, down 0.84 from the previous close
Market Cap20.55bn, indicating a large market presence
P/E Ratio22.93, suggesting fair valuation
Dividend Yield1.74, attractive for income-focused investors
VolatilityModerate, based on the latest move and live volume

Dis-Chem Pharmacies Ltd. Limited Forecast Insights

Bullish bias is limited unless DCP reclaims recent intraday resistance with stronger volume. The current pullback to R23.69, paired with a modest negative move and average liquidity, points to near-term caution. A steadier consumer-staples backdrop can support the share, but momentum remains the decisive factor.

Bearish pressure would strengthen if selling persists below the current price and turnover fails to expand. For now, the setup looks range-bound, with traders watching whether the share can stabilise after the recent decline.

FAQ on Dis-Chem Pharmacies Ltd. Shares

Q1: What are Dis-Chem Pharmacies Ltd. shares?
Answer: Dis-Chem Pharmacies Ltd. shares are ordinary shares listed as DCP on the JSE. They trade at R23.69 today, with a market capitalisation of 20.55bn and a P/E ratio of 22.93, reflecting a sizeable consumer-staples business.

Q2: How can I buy Dis-Chem Pharmacies Ltd. shares?
Answer: You can buy DCP through a JSE-approved trading account with a licensed platform. The current price per share is R23.69, so you’d place a purchase order, review trading costs, and confirm execution based on live market availability.

Q3: What affects the price of Dis-Chem Pharmacies Ltd. shares?
Answer: The share price is influenced by live trading volume, the recent -0.84 move, valuation at 22.93 times earnings, and investor demand for consumer-staples exposure. At R23.69, DCP is also sensitive to income expectations from its 1.74 dividend yield.

Q4: Does Dis-Chem Pharmacies Ltd. pay dividends?
Answer: Yes, the live data shows a dividend yield of 1.74, which indicates the shares do pay a dividend. At the current price of R23.69, income investors can use that yield to assess expected payout relative to price today.

Q5: How can I track my Dis-Chem Pharmacies Ltd. shares and dividends?
Answer: Track DCP through your trading account and monitor the JSE quote, current price of R23.69, and dividend yield of 1.74. The live volume of 26 752 and recent change of -0.84 help you follow price action and dividend-linked performance.

Q6: What factors are affecting the Dis-Chem Pharmacies Ltd. share price?
Answer: The share price is being shaped by the current level of R23.69, the -0.84 daily change, and live volume of 26 752. The sector classification, market cap of 20.55bn, and P/E of 22.93 also influence sentiment.

Q7: Is Dis-Chem Pharmacies Ltd. a good share to buy?
Answer: Based on the live data, DCP may suit investors seeking a large-cap consumer-staples share with a 1.74 dividend yield and moderate valuation at 22.93 P/E. At R23.69, the decision depends on your buy price and risk tolerance.

Q8: Is it advisable to buy Dis-Chem Pharmacies Ltd. shares today?
Answer: The live price today is R23.69, and the share is down 0.84, so buying today depends on whether you want exposure to a large-cap JSE retailer at this price. The moderate volume suggests a measured, not rushed, approach.

Q9: How much does one Dis-Chem Pharmacies Ltd. share cost?
Answer: One Dis-Chem Pharmacies Ltd. share costs R23.69 today. That price per share sits alongside a market cap of 20.55bn, a P/E of 22.93, and a dividend yield of 1.74, giving context for any purchase decision.

Q10: How to sell Dis-Chem Pharmacies Ltd. shares?
Answer: To sell DCP shares, log into your trading account, enter the JSE ticker, and place a sell order at or near the current price of R23.69. Live volume of 26 752 can help gauge liquidity and execution quality.

How to Buy Dis-Chem Pharmacies Ltd. Shares Step by Step

Open a free trading account with a regulated broker.

Verify the account using your email address or phone number.

Set up 2FA for added security.

Complete KYC verification.

Review the dashboard and familiarise yourself with order types.

Deposit funds into your trading account.

Search for DCP on the JSE platform and place your trade.

Dis-Chem Pharmacies Ltd. Actionable Financial Advice

Given Dis-Chem Pharmacies Ltd.'s current performance, investors should HOLD the shares if prices move ABOVE R23.69 and consider reducing exposure if they drift BELOW that level. Monitor macroeconomic developments and sector conditions to refine your strategy.

Latest News On Dis-Chem Shares
XM Footer

Recommended brokers

IC Markets Footer